Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Sell
1,323
-836
-39% -$179K 0.08% 519
2026
Q1
$477K Buy
2,159
+1,009
+88% +$247K 0.14% 269
2025
Q4
$292K Buy
+1,150
New +$289K 0.1% 447

Other funds holding STE

AlphaGrep UK's STE Position: Q2 2026 in Review

AlphaGrep UK reduced its Steris (STE) stake by 39% in Q2 2026, selling an estimated $179K and leaving 1,323 shares worth $279K. The position accounts for 0.08% of the portfolio, ranked #519.

AlphaGrep UK first reported a position in STE in Q4 2025 and has held it in 3 quarters since. The position peaked at $477K in Q1 2026. 785 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • AlphaGrep UK held 1,323 shares of Steris worth $279K as of Q2 2026.
  • AlphaGrep UK sold 836 Steris shares in Q2 2026, an estimated $179K.
  • Steris made up 0.08% of AlphaGrep UK's portfolio in Q2 2026, its #519 holding.
  • AlphaGrep UK first reported a position in Steris in Q4 2025 and has held it in 3 quarters since.
  • AlphaGrep UK's Steris position peaked at $477K in Q1 2026.
  • 785 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.